THE GOAL OF ANTIEMETIC therapy is to prevent nausea and vomiting completely. This
goal is achieved for many patients receiving chemotherapy or radiation therapy, and is …

Tropisetron is a serotonin (5-hydroxytryptamine; 5-HT) antagonist that is primarily used in
the prevention of chemotherapy-induced nausea and vomiting. Antagonism of 5-HT3 …

BACKGROUND Nausea and emesis as a consequence of chemotherapy or radiotherapy
can have an adverse effect on patients' quality of life during cancer treatment and may last …

Purpose Delayed chemotherapy-induced nausea and vomiting (CINV) remains an important
adverse effect of moderately emetogenic chemotherapy not containing anthracyclines and …

Previous studies evaluating the efficacy and tolerance of tropisetron for the treatment of
fibromyalgia (FM) used the drug either intravenously or orally, and at different dosage levels …

In the past few years a combination of a 5-HT3 receptor antagonist plus dexamethasone has
been shown to be the most efficacious antiemetic prophylaxis of acute emesis induced by …

The antiemetic efficacy and tolerability of Tropisetron (Navoban®, Novartis Pharma
Switzerland AG, Bern), a selective 5‐hydroxytriptamine receptor antagonist, has been …

Postoperative nausea and vomiting has been described as the big little problem in
anesthesia, with the overall incidence after anesthesia using volatile anesthetics remaining …

Nausea and vomiting are among the most distressing side-effects of cancer chemotherapy,
and therefore good control of these symptoms is extremely important from the patient's …

Purpose Delayed chemotherapy-induced nausea and vomiting (CINV) remains an important
adverse effect of moderately emetogenic chemotherapy not containing anthracyclines and …